Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
1239588-11-4
133803-81-3
186020-66-6
886362-90-9
518044-32-1
850090-09-4
1975173-67-1 | N-Boc-peg3-benzyl ester | AA019E5E | MFCD30458050
2100306-72-5 | N-(Azido-PEG3)-N-Fluorescein-PEG4-acid | AA019E9G | MFCD30723233
1539292-61-9 | 4-amino-N-(4-(2-cyanoethynyl)phenyl)butanamide | AA019EE4 | MFCD31561121
1255718-36-5 | 1-cyclopentyl-1,4-diazepane bis(4-methylbenzenesulfonate) | AA019EHD | MFCD13193850
76982-28-0 | 2-Methyl-5-nitroquinoxaline | AA019EKN | MFCD18448283
1824263-95-7 | 2-(6-(3-Chlorophenyl)pyridin-2-yl)acetonitrile | AA019ENX | MFCD20038551
925252-83-1 | N'-hydroxy-2-naphthalen-1-ylethanimidamide | AA019EQT | MFCD00207949
1024378-31-1 | 4-bromo-N-(4-bromo-3-fluorophenyl)benzenesulfonamide | AA019EU9 | MFCD20807136
1356163-58-0 | methyl 3,4-dihydro-2H-pyrano[2,3-c]pyridine-6-carboxylate | AA019EXE | MFCD28501403
59-40-5 | 4-Amino-N-(quinoxalin-2-yl)benzenesulfonamide | AA019FPI | MFCD00055406